entinostat and cyc 202
entinostat has been researched along with cyc 202 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Gahr, S; Hahn, EG; Herold, C; Ocker, M; Peter, G; Wissniowski, TT | 1 |
Other Studies
2 other study(ies) available for entinostat and cyc 202
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
The histone-deacetylase inhibitor MS-275 and the CDK-inhibitor CYC-202 promote anti-tumor effects in hepatoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Carcinoma, Hepatocellular; Caspase 3; Caspase 8; Cell Line, Tumor; Enzyme Inhibitors; Flow Cytometry; Humans; Immunohistochemistry; Liver Neoplasms; Purines; Pyridines; Roscovitine | 2008 |